The market growth is driven by the rising global prevalence of obesity, increased awareness of medical weight management solutions, and strong clinical outcomes supporting early adoption
doi:10.1161/CIRCULATIONAHA.116.025338 58
The content provided on this webpage is to provide information only, to be fully-interpreted by a medical professional, and not intended as a guide to make purchase decisions, or a substitute to advice of a medical professional
Secondly, once an individual stops taking a GLP-1, for example because theyve reached their target weight, its really important to stick to healthy eating habits
received unrestricted research grants from Takeda, Johnson & Johnson, Tramedico and Ferring
Fan H, Bhullar KS, Wang Z, Wu J